1. Punthakee Z, Goldenberg R, Katz P. Definition, Classification and Diagnosis of Diabetes, Prediabetes and Metabolic Syndrome. Can J Diabetes. 2018; 42:S10–15.
3. Lovic D, Piperidou A, Zografou I, Grassos H, Pittaras A, Manolis A. The Growing Epidemic of Diabetes Mellitus. Current Vascular Pharmacology. 2020; 18:104–109.
4. Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes, Ohlrogge AW. IDF Diabetes Atlas: Global Estimates of Diabetes Prevalence for 2017 and Projections for 2045. Diabetes Research and Clinical Practice. 2018; 138:271–281.
5. Raposo JF. Diabetes: factos e números 2016, 2017 e 2018. Revista Portuguesa de Diabetes. 2020; 15:19–27.
9. Bertachi A, Ramkissoon CM, Bondia J, Vehí J. Automated Blood Glucose Control in Type 1 Diabetes: A Re-view of Progress and Challenges. Endocrinología, Diabetes y Nutrición (English ed.). 2018; 65:172–181.
10. Ahmad E, Lim S, Lamptey R, Webb DR, Davies MJ. Type 2 Diabetes. The Lancet. 2022; 400:1803–1820.
12. Mack LR, Tomich PG. Gestational Diabetes: Diagnosis, Classification, and Clinical Care. Obstetrics and Gyne-cology Clinics. 2017; 44:207–217.
14. Teixeira J, Bragada J, Coelho J, Pinto I, Magalhaes P. Sensibility and Specificity Analysis for Waist-to-Height Ratio, Body Mass Index and Waist Circumference as a Screening Criterion for Metabolic Syndrome in an Adult North-East Portuguese Population. Obes Facts. 2022; 15:210–211.
17. Lindström J, Tuomilehto J. The Diabetes Risk Score: A Practical Tool to Predict Type 2 Diabetes Risk. Diabetes Care. 2003; 26:725–731.
18. Candeias AC, Pipa C, Boavida JM, Correia LG, Pereira M, Almeida M, Duarte R. Programa nacional de prevenção e controlo da diabetes. Revista Portuguesa de Diabetes. 2007; 2(4):5–13.
19. Saaristo T, Moilanen L, Korpi-Hyövälti E, et al. Lifestyle Intervention for Prevention of Type 2 Diabetes in Primary Health Care: One-Year Follow-up of the Finnish National Diabetes Prevention Program (FIN-D2D). . Diabetes Care. 2010; 33:2146–2151.
20. Gabriel R, Acosta T, Florez K, Anillo L, Navarro E, Boukichou N, Acosta-Reyes J, Barengo NC, Lindström J, Tuomilehto JO, et al. Validation of the Finnish Type 2 Diabetes Risk Score (FINDRISC) with the OGTT in Health Care Practices in Europe. Diabetes Res Clin Pract. 2021; 178:108976
21. Silvestre MP, Jiang Y, Volkova K, Chisholm H, Lee W, Poppitt SD. Evaluating FINDRISC as a Screening Tool for Type 2 Diabetes among Overweight Adults in the PREVIEW:NZ Cohort. Primary Care Diabetes. 2017; 11:561–569.
22. Dantas R, Azevedo T, Alves M, et al. Utilização do FINDRISC no Rastreio da Diabetes em Utentes Assintomáticos. 2017; 12(1):45–51.
23. Valente T, Azevedo L. Estudo RADAR - Risco aumentado de diabetes em Amarante. Revista Portuguesa de Me-dicina Geral e Familiar. 2012; 28:18–24.
24. Viveiros AS, Borges M, Martins R, Anahory B, Cordeiro MS. Estudo LIDIA: Risco de Diabetes Mellitus Tipo 2 Numa População Rural Dos Açores. Revista Portuguesa de Endocrinologia, Diabetes e Metabolismo. 2015; 10:124–127.
25. Ortiz MCA, Zanetti ML. Levantamento dos fatores de risco para diabetes mellitus tipo 2 em uma instituição de ensino superior. Rev. Latino-Am. Enfermagem. 2001; 9:58–63.
26. Aris A, Khalid MZM, Yahaya H, Yoong LO, Ying NQ. Type 2 Diabetes Risk Among University Students in Malaysia. Curr Diabetes Rev. 2020; 16:387–394.
27. American College of Sports Medicine. ACSM’s Guidelines for Exercise Testing and Prescription; Lippincott Williams & Wilkins, 2013; ISBN 978-1-4698-2666-0
28. Misra A, Wasir JS, Vikram NK. Waist Circumference Criteria for the Diagnosis of Abdominal Obesity Are Not Applicable Uniformly to All Populations and Ethnic Groups. Nutrition. 2005; 21:969–976.
29. Agresti, A. An Introduction to Categorical Data Analysis; John Wiley & Sons, 2018; ISBN 978-1-119-40526-9
30. Bland M. An Introduction to Medical Statistics; Oxford University Press, 2015; ISBN 978-0-19-251839-2
31. Fagard RH, Nilsson P.M. Smoking and Diabetes—The Double Health Hazard! Primary Care Diabetes. 2009; 3:205–209.
32. Baliunas DO, Taylor B.J, Irving H, Roerecke M, Patra J, Mohapatra S, Rehm J. Alcohol as a Risk Factor for Type 2 Diabetes: A Systematic Review and Meta-Analysis. Diabetes Care. 2009; 32:2123–2132.
33. Teixeira J, Bragada J, Bragada J, Coelho J, Pinto I, Reis L, Magalhaes P. The Prevalence of Metabolic Syn-drome and Its Components in Bragança District, North-Eastern Portugal: A Retrospective Observational Cross-Sectional Study. . Revista Portuguesa de Endocrinologia Diabetes e Metabolismo. 2022; 17(1-2):51–57.
35. Black CD, Black CM, Pensions GB. Working for a Healthier Tomorrow: Dame Carol Black’s Review of the Health of Britain’s Working Age Population; The Stationery Office, 2008; ISBN 978-0-11-702513-4